Funding for this research was provided by:
Natural Science Foundation of Xinjiang Province (2020D01C259)
National Natural Science Foundation of China (82160054)
State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia Fund (SKL-HIDCA-2019-40)
the Key R&D Program of Xinjiang Uygur Autonomous Region (2020B03002-1, 2020B03002)
Received: 6 January 2022
Accepted: 6 July 2022
First Online: 13 July 2022
: The study conducted according to the standards of the Declaration of Helsinki and its experimental protocols was approved by the Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University. Written informed consent was obtained from all subjects and/or their legal guardian(s). All participants consented for drawing their blood samples and collection of their relevant clinical data.
: Not applicable.
: All of these authors declared that they had no competing interests.